Ohr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings
Feb 14, 2017 12:01 pm UTC| Business
Management to Host a Conference Call and Webcast at 7:45a.m Eastern Time Today NEW YORK, Feb. 14, 2017 -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for...
Cloudera Wins ‘Best Cybersecurity Team of the Year’ in Cybersecurity Excellence Awards
Feb 14, 2017 12:01 pm UTC| Business
RSA 2017 SAN FRANCISCO, Calif., Feb. 14, 2017 -- Cloudera, the global provider of the fastest, easiest, and most secure data management, analytics and machine learning platform built on the latest open source...
Cloudera Wins ‘Best Cybersecurity Team of the Year’ in Cybersecurity Excellence Awards
Feb 14, 2017 12:01 pm UTC| Business
RSA 2017 SAN FRANCISCO, Calif., Feb. 14, 2017 -- Cloudera, the global provider of the fastest, easiest, and most secure data management, analytics and machine learning platform built on the latest open source...
BlueLinx to Announce Fourth Quarter and Full Year Results on March 2nd
Feb 14, 2017 12:01 pm UTC| Business
ATLANTA, Feb. 14, 2017 -- BlueLinx Holdings Inc. (NYSE:BXC), a leading distributor of building and industrial products in the United States will release fourth quarter and full year financial results on Thursday, March...
BlueLinx to Announce Fourth Quarter and Full Year Results on March 2nd
Feb 14, 2017 12:01 pm UTC| Business
ATLANTA, Feb. 14, 2017 -- BlueLinx Holdings Inc. (NYSE:BXC), a leading distributor of building and industrial products in the United States will release fourth quarter and full year financial results on Thursday, March...
Feb 14, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 14, 2017 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that enrollment of an...
Feb 14, 2017 12:01 pm UTC| Business
NEW YORK, Feb. 14, 2017 -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and other products for targeting and treating cancer, today announced that enrollment of an...